Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 42 results for "lacosamide"

Daiichi, UCB file application for partial amendment of approva...

Daiichi Sankyo Company Limited and UCB Japan Co Ltd announced that they have filed an application for partial amendment of approval to use lacosamide (Vimpat├▓ tablets 50 mg and 100 mg) in monotherapy for partial-onset seizure (including secondary ... PharmaBiz, 1 month ago

12 images for lacosamide, 3 months ago
Pharmafile, 3 months ago
Edu Bourse, 3 months ago
Monthly Prescribing Reference, 3 months ago
Edu Bourse, 4 months ago
Monthly Prescribing Reference, 6 months ago
Money Control, 5 months ago
India Infoline, 5 months ago
Central Chronicle, 5 months ago
Money Control, 5 months ago

Lacosamide (CAS 175481-36-4) Global Market Size, Growth, Analysis, Demand And Forecast To 2020: Market Reports Center

(Before It's News) The Global and Chinese Lacosamide (CAS 175481-36-4) Global Market Research Report provides an overview and the current status of the global Lacosamide (CAS 175481-36-4) industrywith a special focus on the Chinese markets. Key ...
 Before It's News2 weeks ago 2016 Global and Chinese Lacosamide (CAS 175481-36-4) Industry Market Research Report  MarketResearch.com4 weeks ago

New and Generic Drug Approvals: Lacosamide

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to
 U.S. Food and Drug Administration1 month ago

Brivaracetam in epilepsy: Added benefit still not proven

An indirect comparison between lacosamide and Brivaracetam for epilepsy treatment is methodologically better and covers more outcomes than the previous indirect comparisons. However, an added benefit still cannot be derived,
 Science Daily2 months ago Added benefit still not proven for epilepsy drug  HealthMediciNet.com2 months ago

UCB's shares rise as US court upholds patent on epilepsy drug Vimpat

UCB announced that a US district court confirmed the validity of a patent related to the epilepsy treatment Vimpat (lacosamide), sending the company's shares up nearly as much as 10 percent Monday. The patent on Vimpat, which generated sales of ...
 CPhI.cn2 months ago US court rules in favour of UCB in patent dispute, shares jump  Pharmafile2 months ago

4 Ways to Manage the Rising Cost of Drugs for Epilepsy and Other Conditions

Research shows that the average price of medications in the U.S. is rising at nearly 10 percent per year. This affects the treatment of epilepsy and other medical conditions. If you or your loved one has epilepsy, then perhaps you will recognize ...
 US News & World Report10 hours ago

Chronic Pain Treatment Pipeline Review H2 2016

Chronic Pain Pipeline Review, H2 2016, provides an overview of the Chronic Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete with analysis by stage of ...
 Before It's News6 days ago Seizures Pipeline H2 2016 Market Review Research Report  International Business Times1 month ago

Global Antiepileptic Drugs Market 2016: Industry Segmentation, Parameters and Prospects 2016 to 2022

Latest industry research report on: Global Antiepileptic Drugs Market 2016: Industry Research, Size, Shares, Key Trends, Demand, Growth to 2022 Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used ...
 Before It's News1 week ago Global Epilepsy Drug Market 2016: Marketed Drugs, First Generation Drugs  Before It's News1 month ago Global Epilepsy Drug Market 2016: By Geography - North America, Europe, AsiaPacific, LAMEA  Before It's News1 month ago Antiepileptic Drugs Market 2016: Global Industry Insights, Statistics, Study and Forecasts to 2022  Digital Journal1 month ago

CPhI Worldwide announces the finalists of the CPhI Pharma Awards 2016

CPhI Worldwidehas announced the finalists for this year's CPhI Pharma Awards. In its 13th anniversary, the awards will honour companies and individuals driving the pharma industry forward through innovations, new approaches, technologies and ...
 CPhI.cn2 weeks ago

Large Pan-European Pooled Analyses of Zebinix® (eslicarbazepine acetate) Real-World Data to Assess Use for Partial Epilepsy in Clinical Practice

/PRNewswire/ -- FOR EMEA MEDIA ONLY - NOT FOR SWISS/AUSTRIAN / CZECH REPUBLIC JOURNALISTS F urther insights into seizure control and safety profile of epilepsy drug in the treatment of newly diagnosed partial o nset (focal) seizures ...
 Biotechgate1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - lacosamide
Get updated on latest news & your favorite topics right in your inbox!
More     Less